U.S. International Development Finance Corporation to work with Indian manufacturer Biological E Ltd. to finance increased capacity to support its effort to produce at least 1 billion doses of COVID-19 vaccines by the end of 2022. 

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)